ACOG (Alpha Cognition) Ending Cash Position: $54.31 Mil (As of Mar. 2026)


ACOG Alpha Cognition Inc ACOG
31 GF Score
Price $8.50
! 3 Warning Signs
View Full Analysis

What is Alpha Cognition Ending Cash Position?

Alpha Cognition ACOG +4.94% 31 Ending Cash Position is $54.31 Mil as of Mar. 2026. GuruFocus rates ACOG with a GF Score™ of 31/100. The stock has 3 warning signs investors should review.

Alpha Cognition's Ending Cash Position for the quarter that ended in Mar. 2026 was $54.31 Mil.

Alpha Cognition's quarterly Ending Cash Position increased from Sep. 2025 ($35.46 Mil) to Dec. 2025 ($66.11 Mil) but then declined from Dec. 2025 ($66.11 Mil) to Mar. 2026 ($54.31 Mil).

Alpha Cognition's annual Ending Cash Position increased from Dec. 2023 ($1.50 Mil) to Dec. 2024 ($48.56 Mil) and increased from Dec. 2024 ($48.56 Mil) to Dec. 2025 ($66.11 Mil).

Alpha Cognition Ending Cash Position Related Terms

Alpha Cognition Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Alpha Cognition's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha Cognition Ending Cash Position Chart

Alpha Cognition Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 11.30 2.08 1.50 48.56 66.11

Alpha Cognition Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.62 39.46 35.46 66.11 54.31
ACOG
31GF Score
Alpha Cognition Inc ACOG
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Cognition Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Alpha Cognition's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=48.563+17.542
=66.11

Alpha Cognition's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=66.105+-11.798
=54.31

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $54.31 Mil mean?
Alpha Cognition (ACOG) has a Ending Cash Position of $54.31 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Alpha Cognition and its competitors.
Is Alpha Cognition's Ending Cash Position too high?
Alpha Cognition's current Ending Cash Position is $54.31 Mil. Overall, Alpha Cognition has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's Ending Cash Position compare to HURA and MENS?
Alpha Cognition's Ending Cash Position of $54.31 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Alpha Cognition and its competitors. Alpha Cognition's current Ending Cash Position is $54.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current Ending Cash Position of $54.31 Mil. The current Ending Cash Position is $54.31 Mil. Alpha Cognition's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current Ending Cash Position is $54.31 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha Cognition Business Description

Other Exchanges 7N70:Germany
Address 1200 - 750 West Pender Street, Vancouver, BC, CAN, V6C 2T8
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
31GF Score

Get the complete analysis for ACOG

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.50
Price